Growth attenuation by commission and omission may be ethically justifiable in children with profound disabilities.
Ross
Lainie Friedman
LF
D002648:Child; D019988:Children with Disabilities; D004992:Ethics, Medical; D006128:Growth / Q000187:drug effects*; D013006:Growth Hormone / Q000008:administration & dosage; D006801:Humans
D013006:Growth Hormone